{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:31Z","timestamp":1786985431568,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","award":["SCR_017829"],"award-info":[{"award-number":["SCR_017829"]}],"id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD028518-1"],"award-info":[{"award-number":["1S10OD028518-1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01 AI139072"],"award-info":[{"award-number":["R01 AI139072"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018088","name":"University of Virginia School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA302570"],"award-info":[{"award-number":["P01 CA302570"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F31 CA271809"],"award-info":[{"award-number":["F31 CA271809"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA171983"],"award-info":[{"award-number":["P01 CA171983"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F99 CA284252"],"award-info":[{"award-number":["F99 CA284252"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA044579"],"award-info":[{"award-number":["P30 CA044579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bneo.2026.100196","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:06:33Z","timestamp":1768388793000},"page":"100196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-0530","authenticated-orcid":false,"given":"Johnson","family":"Ung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-0823","authenticated-orcid":false,"given":"Su-Fern","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J. P.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maansi","family":"Taori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess M.","family":"Deddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9130-2482","authenticated-orcid":false,"given":"Giovana","family":"Venancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McLane M.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-5370","authenticated-orcid":false,"given":"James T.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-344X","authenticated-orcid":false,"given":"Raphael T.","family":"Aruleba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-7087","authenticated-orcid":false,"given":"Upendar R.","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arati","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Bishal","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-7817","authenticated-orcid":false,"given":"Irene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavishya","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-6138","authenticated-orcid":false,"given":"Kevin A.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-628X","authenticated-orcid":false,"given":"Francine","family":"Garrett-Bakelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles C.","family":"Cabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-829X","authenticated-orcid":false,"given":"Kelsey H.","family":"Fisher-Wellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Claxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Chalfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Feith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J"},{"issue":"20","key":"10.1016\/j.bneo.2026.100196_bib2","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.3390\/cancers14204995","article-title":"Targeting apoptosis in AML: where do we stand?","volume":"14","author":"Krawiec","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.bneo.2026.100196_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.bneo.2026.100196_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bneo.2026.100196_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.18.01600","article-title":"Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib\/II study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.bneo.2026.100196_bib8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood.2020004856","article-title":"Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial","volume":"135","author":"Wei","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bneo.2026.100196_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bneo.2026.100196_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41419-024-06810-7","article-title":"Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia","volume":"15","author":"Nwosu","year":"2024","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.bneo.2026.100196_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5102","key":"10.1016\/j.bneo.2026.100196_bib12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.bneo.2026.100196_bib14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1194\/jlr.RA119000251","article-title":"Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells","volume":"60","author":"Kao","year":"2019","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.bneo.2026.100196_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(95)90429-8","article-title":"Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals","volume":"82","author":"Bose","year":"1995","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bneo.2026.100196_bib16","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/j.1460-2075.1996.tb00599.x","article-title":"Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis","volume":"15","author":"Jaffr\u00e9zou","year":"1996","journal-title":"The EMBO Journal"},{"issue":"50","key":"10.1016\/j.bneo.2026.100196_bib17","doi-asserted-by":"crossref","first-page":"83208","DOI":"10.18632\/oncotarget.13079","article-title":"Acid ceramidase is upregulated in AML and represents a novel therapeutic target","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.bneo.2026.100196_bib18","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood-2016-04-708750","article-title":"Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML","volume":"128","author":"Dany","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bneo.2026.100196_bib19","doi-asserted-by":"crossref","first-page":"e22514","DOI":"10.1096\/fj.202200765R","article-title":"Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia","volume":"36","author":"Khokhlatchev","year":"2022","journal-title":"The FASEB Journal"},{"issue":"6","key":"10.1016\/j.bneo.2026.100196_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1194\/jlr.M091876","article-title":"Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kB-dependent P-glycoprotein upregulation","volume":"60","author":"Tan","year":"2019","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.bneo.2026.100196_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1541-7786.MCR-19-0619","article-title":"Ceramide analogue SACLAC modulates sphingolipid levels and MCL-1 splicing to induce apoptosis in acute myeloid leukemia","volume":"18","author":"Pearson","year":"2020","journal-title":"Mol Cancer Res"},{"issue":"24","key":"10.1016\/j.bneo.2026.100196_bib22","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.3390\/cancers15245866","article-title":"Acid ceramidase inhibitor LCL-805 antagonizes Akt signaling and promotes iron-dependent cell death in acute myeloid leukemia","volume":"15","author":"Ung","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"W1","key":"10.1016\/j.bneo.2026.100196_bib23","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.bneo.2026.100196_bib24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bneo.2026.100196_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.101036","article-title":"Acute myeloid leukemia resistant to venetoclax-based therapy: what does the future hold?","volume":"59","author":"Dhakal","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.bneo.2026.100196_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109838","article-title":"On the nature of ceramide-mitochondria interactions \u2013 dissection using comprehensive mitochondrial phenotyping","volume":"78","author":"Fisher-Wellman","year":"2021","journal-title":"Cell Signal"},{"issue":"4","key":"10.1016\/j.bneo.2026.100196_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies","volume":"36","author":"Gui\u00e8ze","year":"2019","journal-title":"Cancer Cell"},{"issue":"W1","key":"10.1016\/j.bneo.2026.100196_bib28","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/BJ20130147","article-title":"BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins","volume":"452","author":"Beverly","year":"2013","journal-title":"Biochem J"},{"issue":"26","key":"10.1016\/j.bneo.2026.100196_bib30","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1182\/blood.2021013277","article-title":"Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia","volume":"139","author":"Lewis","year":"2022","journal-title":"Blood"},{"issue":"6489","key":"10.1016\/j.bneo.2026.100196_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bneo.2026.100196_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bjh.18968","article-title":"Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress\u2014CHOP pathway","volume":"202","author":"Hua","year":"2023","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.bneo.2026.100196_bib33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-23-2543","article-title":"Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to chemotherapy in acute myeloid leukemia","volume":"84","author":"Jin","year":"2024","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bneo.2026.100196_bib34","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI130809","article-title":"A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia","volume":"130","author":"Williams","year":"2020","journal-title":"J Clin Invest"},{"issue":"516","key":"10.1016\/j.bneo.2026.100196_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.bneo.2026.100196_bib36","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/1078-0432.CCR-19-1900","article-title":"5-azacitidine induces NOXA to prime AML cells for venetoclax-mediated apoptosis","volume":"26","author":"Jin","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41420-022-01009-1","article-title":"The BCL-2 inhibitor ABT-199\/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA","volume":"8","author":"Weller","year":"2022","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.bneo.2026.100196_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107151","article-title":"The integrated stress response in metabolic adaptation","volume":"300","author":"Ryoo","year":"2024","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.bneo.2026.100196_bib39","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1093\/nar\/gkaa757","article-title":"Ribosomal stress-surveillance: three pathways is a magic number","volume":"48","author":"Vind","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.bneo.2026.100196_bib40","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.bneo.2026.100196_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bneo.2026.100196_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal Biochem"},{"issue":"13","key":"10.1016\/j.bneo.2026.100196_bib43","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1016\/j.celrep.2018.08.091","article-title":"Mitochondrial diagnostics: a multiplexed assay platform for comprehensive assessment of mitochondrial energy fluxes","volume":"24","author":"Fisher-Wellman","year":"2018","journal-title":"Cell Rep"},{"issue":"15","key":"10.1016\/j.bneo.2026.100196_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu5511","article-title":"Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy","volume":"11","author":"Hagen","year":"2025","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.bneo.2026.100196_bib45","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2026.100196_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054525","article-title":"Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins","volume":"8","author":"Casson","year":"2013","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.bneo.2026.100196_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","article-title":"Revisiting the sphingolipid rheostat: evolving concepts in cancer therapy","volume":"333","author":"Newton","year":"2015","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.bneo.2026.100196_bib48","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood-2016-06-720433","article-title":"Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia","volume":"129","author":"Powell","year":"2017","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bneo.2026.100196_bib49","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1074\/jbc.M011400200","article-title":"Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX","volume":"276","author":"Ruvolo","year":"2001","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.bneo.2026.100196_bib50","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/pmic.201100527","article-title":"Identification of C6-ceramide-interacting proteins in D6P2T Schwannoma cells","volume":"12","author":"Kota","year":"2012","journal-title":"Proteomics"},{"issue":"5","key":"10.1016\/j.bneo.2026.100196_bib51","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1042\/BST20190331","article-title":"Towards a model of GCN2 activation","volume":"47","author":"Masson","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bneo.2026.100196_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.584974","article-title":"Targeting Bcl-2 proteins in acute myeloid leukemia","volume":"10","author":"Wei","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.bneo.2026.100196_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1226289","article-title":"Targeting MCL-1 protein to treat cancer: opportunities and challenges","volume":"13","author":"Tantawy","year":"2023","journal-title":"Front Oncol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:27:41Z","timestamp":1779294461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2950328026000075"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100196","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100196"}}